BioGaia AB - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for BioGaia AB Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

BioGaia AB. The Group's principal activities are the research, development and manufacturing of probiotic systems that build health in humans and animals. The products of the Group are based on the lactic acid bacterium Lactobacillus reuteri in combination with delivery systems that make it possible to create products with a long shelf life. Reuteri that has probiotic or health-enhancing effects occurs naturally in the intestinal flora of humans and animals. It inhibits the proliferation of harmful bacteria and promotes the growth of the normal intestinal microflora, thereby strengthening the immune system. The trademarks of the Group include Reuteri (R), LifeTop Straw and LifeTop Cap.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report